Explorations fonctionnelles respiratoires - SPLF

Stratégies d’interprétation des explorations fonctionnelles respiratoires90 Peto R, Speizer FE, Cochrane AL, et al. : The relevance in adults ofair-flow obstruction, but not of mucus hypersecretion, to mortalityfrom chronic lung disease; results from 20 years of prospective observation.Am Rev Respir Dis 1983 ; 128 : 491-500.91 Neas LM, Schwartz J : Pulmonary function levels as predictors ofmortality in a national sample of US adults.Am J Epidemiol 1998 ;147 : 1011-18.92 Ferguson MK, Little L, Rizzo L, et al. : Diffusing capacity predictsmorbidity and mortality after pulmonary resection. J Thorac CardiovascSurg 1988 ; 96 : 894-900.93 Black LF, Hyatt RE : Maximal static respiratory pressures in generalizedneuromuscular disease. Am Rev Respir Dis 1971 ; 103 : 641-50.94 Fairshter RD : Airway hysteresis in normal subjects and individualswith chronic airflow obstruction. J Appl Physiol 1985 ; 58 : 1505-10.95 Zamel N, Hughes D, Levison H, Fairshter RD, Gelb AF : Partial andcomplete maximum expiratory flow-volume curves in asthmaticpatients with spontaneous bronchospasm. Chest 1983 ; 83 : 35-9.96 Burns CB, Taylor WR, Ingram RH Jr : Effects of deep inhalation inasthma : relative airway and parenchymal hysteresis. J Appl Physiol1985 ; 59 : 1590-96.97 Brusasco V, Pellegrino R, Violante B, Crimi E : Relationship betweenquasi-static pulmonary hysteresis and maximal airway narrowing inhumans. J Appl Physiol 1992 ; 72 : 2075-80.98 Pellegrino R, Wilson O, Jenouri G, Rodarte JR : Lung mechanicsduring bronchoconstriction. J Appl Physiol 1996 ; 81 : 964-975.99 Koulouris NG, Valta P, Lavoie A, Corbeil C, Chasse M, Braidy J,Milic-Emili J : A simple method to detect expiratory flow limitationduring spontaneous breathing. Eur Respir J 1995 ; 8 : 306-13.100 Eltayara L, Becklake MR, Volta CA, Milic-Emili J : Relationshipbetween chronic dyspnea and expiratory flow limitation in patientswith chronic obstructive pulmonary disease. Am J Respir Crit CareMed 1996 ; 154 : 1726-34.101 Pellegrino R, Rodarte JR, Brusasco V : Assessing the reversibility ofairway obstruction. Chest 1998 ; 114 : 1607-12.102 Pellegrino R, Brusasco V : Lung hyperinflation and flow limitation inchronic airway obstruction. Eur Respir J 1997 ; 10 : 543-9.103 Pellegrino R, Brusasco V : On the causes of lung hyperinflationduring bronchoconstriction. Review. Eur Respir J 1997 ; 10 : 468-75.104 Fessler HE, Scharf SM, Permutt S : Improvement in spirometry followinglung volume reduction surgery. Application of a physiologicalmodel. Am J Respir Crit Care Med 2002 ; 165 : 34-40.105 Casanova C, Cote C, de Torres JP, et al. : Inspiratory-to-total lungcapacity ratio predicts mortality in patients with chronic obstructivepulmonary disease. Am J Respir Crit Care Med 2005 ; 171 : 591-7.106 Stark-Leyva KN, Beck KC, Johnson BD : Influence of expiratoryloading and hyperinflation on cardiac output during exercise. J ApplPhysiol 2004 ; 96 : 1920-7.107 Guyatt GH, Townsend M, Nogradi S, Pugsley SO, Keller JL,Newhouse MT : Acute response to bronchodilator, an imperfectguide for bronchodilator therapy in chronic airflow limitation. ArchIntern Med 1988 ; 148 : 1949-52.108 Lorber DB, Kaltenborn W, Burrows B : Responses to isoproterenol ina general population sample. Am Rev Respir Dis 1978 ; 118 : 855-61.109 Dales RE, Spitzer WO, Tousignant P, Schechter M, Suissa S : Clinicalinterpretation of airway response to a bronchodilator : epidemiologicconsiderations. Am Rev Respir Dis 1988 ; 138 : 317-20.110 Watanabe S, Renzetti AD Jr, Begin R, Bigler AH : Airway responsivenessto a bronchodilator aerosol. Am Rev Respir Dis 1974 ; 109 : 530-7.111 Anthonisen NR, Wright EC, the IPPB Trial group : Bronchodilatorresponse in chronic obstructive pulmonary disease. Am Rev Respir Dis1986 ; 133 : 814-819.112 Sourk RL, Nugent KM : Bronchodilator testing: confidence intervalsderived from placebo inhalations. Am Rev Respir Dis 1983 ; 128 :153-7.113 Tweddale PM, Alexander F, McHardy GJR : Short term variability inVEMS and bronchodilator responsiveness in patients with obstructiveventilatory defects. Thorax 1987 ; 42 : 487-90.114 Eliasson O, Degraff AC Jr : The use of criteria for reversibility andobstruction to define patient groups for bronchodilatortrials: influence of clinical diagnosis, spirometric and anthropometricvalues. Am Rev Respir Dis 1985 ; 132 : 858-64.115 Brand PL, Quanjer PhH, Postma DS, et al. : Interpretation ofbronchodilator response in patients with obstructive airways disease.Thorax 1992 ; 47 : 429-36.116 Olsen CR, Hale FC : A method for interpreting acute response tobronchodilators from the spirogram. Am RevRespir Dis 1968 ; 98 :301-2.117 Boggs PB, Bhat KD, Velovius WA, Debo MS : The clinical significanceof volume adjusted maximal mid expiratory flow (iso-volumeFEF25-75 %) in assessing airway responsiveness to inhaled bronchodilatorin asthmatics. Ann Allergy 1982 ; 48 : 139-42.118 Redelmeier DA, Goldstein RS, Min ST, Hyland RH : Spirometryand dyspnea in patients with COPD. When small differences meanlittle. Chest 1996 ; 109 : 1163-8.119 Barnes PJ, Gribbin HR, Osmanliev D, Pride NB : Partial flow-volumecurves to measure bronchodilator dose-response curves in normalhumans. J Appl Physiol 1981 ; 50 : 1193-7.120 Wang JW, McFadden ER, Ingram RH Jr : Effects of increasing dosesof b-agonists on airway and parenchymal hysteresis. J Appl Physiol1990 ; 68 : 363-8.121 Berry RB, Fairshter RD : Partial and maximal expiratory flow-volumecurves in normal and asthmatic subjects before and after inhalation ofmetaproterenol. Chest 1985 ; 88 : 697-702.122 O’Donnell DE : Assessment of bronchodilator efficacy in symptomaticCOPD. Is spirometry useful? Chest 2000 ; 117 : 42S-47S.123 O’Donnell DE, Lam M, Webb KA : Spirometric correlates ofimprovement in exercise performance after cholinergic therapy inchronic obstructive pulmonary disease. Am J Respir Crit Care Med1999 ; 160 : 542-9.124 Cerveri I, Pellegrino R, Dore R, et al. : Mechanisms for isolatedvolume response to a bronchodilator in patients with COPD. J ApplPhysiol 2000 ; 88 : 1989-95.125 Empey DW : Assessment of upper airways obstruction. BMJ 1972 ;3 : 503-5.126 Miller MR, Pincock AC, Oates GD, Wilkinson R, Skene-Smith H :Upper airway obstruction due to goitre: detection, prevalence andresults of surgical management. Q J Med 1990 ; 74 : 177-88.127 Miller RD, Hyatt RE : Obstructing lesions of the larynx and trachea.Mayo Clin Proc 1969 ; 44 : 145-61.128 Pedersen OF, Ingram RH Jr : Configuration of maximum expiratoryflow-volume curve : model experiments with physiological implications.J Appl Physiol 1985 ; 58 : 1305-13.129 Miller MR, Pedersen OF : Peak flow meter resistancedecreases peakexpiratory flow in subjects with COPD. J Appl Physiol 2000 ; 89 :283-90.130 Gibson GJ : Central airway obstruction. In: Clinical Tests of RespiratoryFunction. 2nd edn. London, Chapman&Hall, 1996 ; pp. 194-202.131 Lebowitz MD, Quackenboss J, Camilli AE, Bronnimann D,Holberg CJ, Boyer B : The epidemiological importance of intraindividualchanges in objective pulmonary responses. Eur J Epidemiol1987 ; 3 : 390-8.© 2006 SPLF. Édité par Elsevier Masson SAS. Tous droits réservés 17S103